Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 46 min ago
PreprintAll rights reservedbioRxiv

MYC-Hyperactivated Osteosarcoma Models Exhibit Resistance to Cabozantinib plus TIGIT Blockade

  • S. S. Kappa
  • T. Patel
  • B. Nirala
  • L. Kurenbekova
  • R. Shuck
  • J. T. Yustein1
  1. 1Emory University
Read full textPDFDOICite

Related

  1. Resistance‐trained young men exhibit enhanced carotid vasoreactivity during the cold pressor test
    Ian Hornby‐Foster, Cory T. Richards, Aimee L. Drane +7
    Experimental physiologyPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Site-specific immune remodeling underlies resistance to dual immune checkpoint blockade in metastatic colorectal cancer
    I. Baraibar, S. Morabito, G. Deuner-Cos +25
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  3. Spatial ligand–receptor circuits in osteosarcoma: immune resistance in bone and lung niches
    Yijian Qiu, Shuai Deng, Junfeng Zhou +5
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  4. TPX2 promotes osteosarcoma progression by conferring ferroptosis resistance through the AURKA/NRF2 signaling axis
    Huashun Liu, Lan Tang, Biao Chen +1
    Journal of Bone OncologyPeer-reviewedCC BY-NC-ND 4.0Full textOncologyDOAJPMC
  5. ESCRT-dependent YAP degradation by AKT blockade overcomes adaptive resistance to RAS(ON) inhibition in pancreatobiliary cancer
    Jack W. Sample, Enis H. Ozmert, Brandon A. Wilbanks +16
    bioRxivPreprintCC BYFull textOncologybioRxivPMC

Cite

BibTeXRIS
BibTeX
@misc{kappa2026mychyperactivated,
  title = {{MYC-Hyperactivated Osteosarcoma Models Exhibit Resistance to Cabozantinib plus TIGIT Blockade}},
  author = {S. S. Kappa and T. Patel and B. Nirala and L. Kurenbekova and R. Shuck and J. T. Yustein},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.21.753033},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.21.753033v1},
}
RIS
TY  - UNPB
TI  - MYC-Hyperactivated Osteosarcoma Models Exhibit Resistance to Cabozantinib plus TIGIT Blockade
AU  - S. S. Kappa
AU  - T. Patel
AU  - B. Nirala
AU  - L. Kurenbekova
AU  - R. Shuck
AU  - J. T. Yustein
PY  - 2026
DA  - 2026/09/21
PB  - bioRxiv
DO  - 10.64898/2026.09.21.753033
UR  - https://www.biorxiv.org/content/10.64898/2026.09.21.753033v1
ER  -